Approval · Notice of Compliance 22802 · 2019
ZOMIG: Notice of Compliance 22802
Issued October 18, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22802
- Date
- October 18, 2019
- Company
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- Update packaging components
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZOMIG | Not yet assigned | — |
| ZOMIG RAPIMELT | Not yet assigned | — |
Medicinal ingredients
- ZOLMITRIPTAN 2.5 MG per TAB